Prognostic Significance of Neutrophil-To-Lymphocyte Ratio (Nlr) and Platelet-To-Lymphocyte Ratio (Plr) in Non-Small Cell Lung Cancer (Nsclc) Treated with Immune Checkpoint Inhibitors
Esmo Targeted Anticancer Therapies Congress (Tat), Date: FEB 25-27, 2019, Location: Paris, FRANCE, Sponsors: European Soc Med Oncol, Japanese Soc Med Oncol
